BeOne Medicines AG ( ONC) - Key Metrics
ONC Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $15.28 | $2.12 | $5.95 | $5.34 |
| 2026Q1 | $13.64 | $2.05 | $1.82 | $1.45 |
| 2025Q4 | $13.74 | $0.61 | $3.83 | $1.20 |
| 2025Q3 | $12.81 | $1.13 | $3.65 | $3.22 |
| 2025Q2 | $12.11 | $0.87 | $2.43 | $1.84 |
ONC Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | 2.63 |
| 2026Q1 | 0% | 2.79 |
| 2025Q4 | 0% | 9.90 |
| 2025Q3 | 0% | 5.80 |
| 2025Q2 | 0% | 69.69 |
ONC Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q2 | 1.87% | 0% |
| 2026Q1 | 0.49% | 0% |
| 2025Q4 | 0.40% | 0% |
| 2025Q3 | 0.94% | 0% |
| 2025Q2 | 0.76% | 0% |
ONC
Price: $376.86
52 week price:
Earnings Per Share: 5.60 USD
P/E Ratio: 64.16
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 40.6 billion